BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 2007
View Archived Issues
Clinical studies of new drugs to treat disorders of reduced GI motility
Read More
Novel immunosuppressants disclosed by Sankyo
Read More
Recent Tsumura patents impart novel therapeutic agents for diabetic retinopathy
Read More
New treatments for musculoskeletal and connective tissue disorders claimed in recent patents
Read More
Efficacy and safety of linaclotide acetate in women with constipation-predominant IBS
Read More
PSN-GK1: a glucokinase activator with glucose-lowering and insulinotropic activity in vivo
Read More
Clinical research reported at the 2007 Society of Biological Psychiatry meeting
Read More
New ceramide derivatives beneficial in models of chronic skin inflammatory disease
Read More
Dexloxiglumide shows utility for c-IBS in phase III trial
Read More
Phase I study under way for ABT-107
Read More
Oral calcitonin begins phase III for treatment of osteoarthritis
Read More
Nycomed and Micromet to develop anti-GM-CSF antibodies
Read More
Marketing agreement signed for PSD-502 for premature ejaculation
Read More
U.S. orphan drug designation for Vekacia in vernal keratoconjunctivitis
Read More
VaxGen discontinues development of recombinant anthrax vaccine
Read More
New site added in phase II trial of atiprimod in advanced carcinoid cancer
Read More
Exjade labeling receives new Warning and Adverse Reactions information
Read More
New phase II/III trial investigates CDX-110 in glioblastoma multiforme
Read More
Exelixis files IND for XL-019
Read More
Preterax evaluation closes in ADVANCE diabetes trial
Read More
Sanofi-aventis recaps quarterly highlights
Read More
CHMP hands down negative opinion for Vectibix in metastatic colorectal cancer
Read More
Increlex recommended for approval in E.U.
Read More
Novel xanthine oxidase inhibitors for gout emerge from Kissei R&D
Read More
